Dr. Mahmud is professor and chief of Cardiovascular Medicine, director of Sulpizio Cardiovascular Center, and director of Interventional Cardiology at the University of California, San Diego. Dr. Mahmud pursued his B.Sc. (Medical Science) from the University of Alberta, Edmonton, Canada (1983-1985). He did his Doctorate of Medicine (M.D.) from the University of Alberta, Edmonton, Canada. He completed fellowships in coronary and peripheral vascular interventions at Emory University in Atlanta and cardiovascular medicine at UC San Diego. He completed his internal medicine residency at UC San Diego and earned his medical degree at the University of Alberta in Edmonton, Canada. He is board-certified in cardiovascular medicine and interventional cardiology, and is a Fellow of the Society of the Royal College of Physicians and Surgeons of Canada, Society for Cardiac Angiography and Interventions, and the American College of Cardiology. He has been voted one of the top physicians in San Diego by the San Diego county medical society and among the top 1 percent of interventional cardiologists in the nation by U.S. News & World Report. He has extensively published and serves in leadership capacity for various medical societies. Dr. Mahmud directs the interventional clinical trials center. Under Dr. Mahmud’s leadership, the Interventional Cardiology program is among the largest academic interventional programs in the western United States.

Dr. Mahmud research interests include investigational pharmacotherapies, devices used in cardiovascular interventions, and robotic interventions.

PubMed

Dr. Matthews is Professor of Clinical Medicine and Chief of Cardiovascular Medicine University of south Carolina. He completed his B.S with Honors, in Biochemistry from the University of Wyoming, Doctor of Medicine, Creighton University School of Medicine (1982). He did his fellowships at Harbor/UCLA Medical Center, Cardiovascular Disease (1985 – 1987) and Good Samaritan Hospital, Interventional Cardiology (1987 – 1989). He was recruited to the University of Southern California faculty in 2007 to direct the Department of Interventional Cardiology. He brings 20 years of experience in high-level tertiary interventional cardiology to the institution. Dr. Matthews has emerged as a leader in the advancement of percutaneous treatment of peripheral vascular disease. He remains very active in the clinical investigation and use of new devices and techniques for the treatment of coronary artery disease and carotid artery disease. In addition, Dr. Matthews was among the first in Los Angeles to percutaneously close structural cardiac defects, such as atrial septal defect and to patent foreman ovale. Dr. Matthews previously served as head of an interventional cardiology training program that trained over 50 interventional cardiologists.

Dr. Matthews research interest includes Peripheral Vascular Disease, Interventional Cardiology,Stenting, Heart Attack.

PubMed

Dr. Anatoly Langer is Professor of Medicine at the University of Toronto and the chair of the Canadian Heart Research Centre in Toronto. He was graduated from the University of Manitoba in 1982 and completed his Internal Medicine and Cardiology training at the University of Toronto in 1987. He is a fellow of the American College of Cardiology and Canadian Royal College of Physicians and Surgeons. After two years as a Heart and Stroke Foundation Research Fellow he became a director of the Coronary Care Unit at St. Michael’s Hospital in Toronto, Canada. In 1996 Dr. Langer founded Canadian Heart Research Centre. Dr. Langer has over 250 peer reviewed publications, abstracts, and book chapters.

Dr. Anatoly Langer areas of interest and research include pathophysiology and management of acute and stable coronary syndromes as well as treatment and prevention of cardiovascular disease.

PubMed

Dr. Shaodong Guo is an Associate Professor in the Department of Medical Physiology at Texas A&M University Health Science Center, USA. He received his Ph.D. in Physiology from Beijing University (1995). He completed his B.S. in Biochemistry from Central China University of Agriculture (1989). Dr. Shaodong was a Research Fellow in Molecular Medicine, Vascular Biology and Endocrinology, Department of Medicine at Beth Israel Deaconess Medical Center, Brigham and Women's Hospital and Children's Hospital in Harvard Medical School, Harvard University, Boston MA (2001-2006). He worked as a Research Associate in Endocrinology, Department of Medicine, The University of Illinois at Chicago (1997-2001). He received many honors and awards.

Dr. Guo’s research interests include the mechanisms of diabetes mellitus and associated cardiovascular dysfunction, focusing on insulin, glucagon, and beta-adrenergic receptor signal transduction, insulin resistance, gene transcriptional control of nutrient homeostasis and diabetes-induced heart failure. His long term goal is to develop diabetes and cardiovascular medicine, by identifying components of the IRS/FoxO regulatory network that can be targeted for therapeutic or nutritional intervention for diabetes mellitus and cardiac dysfunction. Dr. Guo’s current research programs have been supported by the American Diabetes Association, American Heart Association, Texas A&M Health Science Center, and the National Institute of Health.

PubMed

Dr. Adel Elmoselhi is an Associate Professor in the Medical College at University of Sharjah, UAE and an Adjunct Associate professor in the Physiology Department at Michigan State University, College of Human Medicine, USA. He has an MD from Alexandria University, Egypt and completed his PhD in 1999 from the Medical Sciences Program (Physiology /Pharmacology) at McMaster University, Ontario, Canada. He also finished two postdoctoral fellowships: one at Toronto General Hospital, Toronto, Canada, and the other at St. Boniface Hospital Research Center, Winnipeg, Manitoba, Canada. Dr. Elmoselhi passion throughout his career has been the basic, translational and clinical sciences in the area of Cardiovascular research; in particular, oxidative stress, ischemia-reperfusion injuries, hypertensive transgenic model, endothelium dysfunction, diabetes mellitus, obesity, non-invasive diagnostic tests to detect and prevent early CVD in high risk patients. He has published several original papers and abstracts in highly cited peer review journals and received several prestigious research awards.

Dr. Adel Elmoselhi research interests include Basic, translational and clinical sciences research, i.e. Oxidative stress and anti-oxidants in cardiovascular disorders; Phenotype of binary transgenic mice model (tTA+/ET1+) with conditional expression of endothelin 1 (ET-1) in vascular smooth muscle; Examine the effect of preconditioning of the heart on ischemia/reperfusion injury; Determine the effect of reactive oxygen species on Na+-K+ pump and intracellular Ca2+ regulators in vascular smooth muscle especially SERCA, IP3 and ryanodine channels; Non-invasive tests in early detection and prevention of cardiovascular diseases in high risk population such as metabolic syndrome, diabetic, obese and vitamin D deficiency patients. He is also interested in educational research i.e. Medical school curriculum development, assessment and student competency; PBL and TBL in the medical curriculum; Hands-on experiences and early clinical integration in medical programs.

PubMed

Dr. Alex Pui-Wai Lee is an Associate professor in the Division of Cardiology, Department of Medicine and Therapeutics, Faculty of Medicine, Shaw College, The Chinese University of Hong Kong. He did his MBChB (Hon) from The Chinese University of Hong Kong (1995 – 2000). Completed his MRCP (UK), Royal College of Physicians, UK (2004). He earned his MD from The Chinese University of Hong Kong (2015). More recently, his group discovered the link between mitral annular saddle shape and progression of regurgitation using 3-dimensional echocardiography (Circulation 2013). Dr. Alex Pui-Wai Lee has been invited as speaker and faculty member in major scientific conferences organized by the American Heart Association, the European Society of Cardiology, the American Society of Echocardiography, and European Association of Cardiovascular Imaging. He has received many honors and awards. He has published 164 research articles and 100 conference papers and two book chapters.

Dr. Alex Pui-Wai Lee main research interests Cardiac imaging ,Valvular heart disease, Structural heart intervention echocardiography, Heart failure.

PubMed